Answers are grounded in this paper and cite their sources.
Viruses attach to cells as a result of binding of a viral attachment protein to a site on a host-cell receptor. Unlike other portions of viral polypeptides, the attachment protein is likely to be highly conserved among strains of viruses that bind to the same receptor. Thus, it may represent the Achilles heel at which therapeutic agents can be targeted. Thomas Lentz reviews the nature of binding domains on viral attachment proteins and on their cellular receptors and discusses the types of agent that act by competing binding of virus to receptors. Characterization of virus-receptor interactions at a molecular level will permit the rational design and production of agents that prevent virus attachment. Of particular promise are designed analogs of the binding site of the receptor (receptor-mimics) that have the ability to bind to the- viral attachment protein.
No takes yet. Share an insight, caveat, or question.
Thomas L. Lentz (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: